Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 4Gastrointestinal 1

Conditions

Colorectal Neoplasms 6Pancreatic Neoplasms 2Gastrointestinal Diseases 2Sleep Wake Disorders 1Sarcopenia 1Prostatic Neoplasms 1Pathologically Proven Gastrointestinal Malignancy 1Neoplasms 1Motor Activity 1Lung Neoplasms 1Fatigue 1Esophageal Neoplasms 1Depression 1Colonic Neoplasms 1Clinical Stage I Esophageal Adenocarcinoma American Joint Committee on Cancer (AJCC) v8 1Anxiety Disorders 1

Interventions

pembrolizumab 17Surveys and Questionnaires 12Specimen Handling 11Docetaxel 11Nivolumab 9Interviews as Topic 9Standard of Care 8Gemcitabine 8Early Intervention, Educational 8olaparib 7enzalutamide 7Magnetic Resonance Spectroscopy 7Psychiatric Rehabilitation 6Paclitaxel 6durvalumab 5Trastuzumab 5Radiotherapy 5Ipilimumab 5Carboplatin 5Bevacizumab 5pertuzumab 4palbociclib 4cabozantinib 4atezolizumab 4abiraterone 4Therapeutics 4Taxes 4Oxaliplatin 4Methods 4Immunoglobulin G 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Prostatic Neoplasms × Exercise Test × Gastrointestinal × Clear all
NCT06016725 2026-01-02

E-PROOF

Ohio State University Comprehensive Cancer Center

Phase NA Completed
75 enrolled 27 charts
GastrointestinalGenitourinary

Prostatic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡